ACCESSION: MSBNK-SMB_Measured-HSA015P0114020
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 16
COMMENT: RAW_SPEC {'EL23_pos_1237': {'bp': 2879673.0, 'sum': 7112529.0}, 'EL06_pos_1239': {'bp': 1848059.0, 'sum': 5837964.0}, 'EL11_pos_1233': {'bp': 1985990.0, 'sum': 5779920.0}, 'EL05_pos_1233': {'bp': 2084542.0, 'sum': 6601911.0}, 'EL20_pos_1233': {'bp': 1823681.0, 'sum': 5576527.0}, 'EL19_pos_1239': {'bp': 1892369.0, 'sum': 5849973.0}, 'EL07_pos_1237': {'bp': 2337547.0, 'sum': 6195312.0}, 'EL22_pos_1239': {'bp': 2030734.0, 'sum': 6151515.0}, 'EL04_pos_1245': {'bp': 1694295.0, 'sum': 4962246.0}, 'EL24_pos_1243': {'bp': 2058435.0, 'sum': 6087030.0}, 'EL09_pos_1233': {'bp': 1980654.0, 'sum': 6126791.0}, 'EL18_pos_1239': {'bp': 1738735.0, 'sum': 4874470.0}, 'EL16_pos_1233': {'bp': 1668225.0, 'sum': 5337457.0}, 'EL08_pos_1239': {'bp': 1615622.0, 'sum': 4834207.0}, 'EL15_pos_1239': {'bp': 1867948.0, 'sum': 5366680.0}, 'EL10_pos_1233': {'bp': 1719668.0, 'sum': 5101751.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 114.091761
COMMENT: PRECURSOR_M/Z_STDEV 0.000046
COMMENT: PRECURSOR_IN_MS1 mz 114.091346; int 136.152; delta(ppm) 0.668423
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.062; C6H11NO; [M+H]+; delta(ppm) 0.061901
COMMENT: PROPOSED_MF MS-FINDER 3.239; C6H11NO; [M+H]+; delta(ppm) 0.057741
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.319; C6H11NO; [M+H]+; delta(ppm) 0.057741
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) 0.057741
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.903; C6H11NO; [M+H]+; delta(ppm) 0.057741
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.279; C4H9N4; [M+H]+; delta(ppm) 11.826202
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) 0.057741
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.308; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; C\C=C(/C)CC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.902; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; CC1(CC=CN1O)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.842; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; C(CCC#N)CCO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.827; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; CC[C@H]1CCNC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.818; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; O=C(C(=CN)C)CC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.319; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.172; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.057; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.027; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.027; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.027; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.975; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.975; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.963; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.947; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.940; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.923; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.894; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.894; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.871; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.871; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.819; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.774; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.537; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.535; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.533; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.530; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.524; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.450; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.448; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.445; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.445; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.437; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.434; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.337; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.129; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.090; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.090; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.087; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.073; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.072; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.072; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.633; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; azepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.705; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.649; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.308; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; N-cyclohexylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; AAQLNWLDUWCQOD-LURJTMIESA-N; [M+H]+; (2S)-2-aminohex-5-yn-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; JUUPISMKQGJUEL-UHFFFAOYSA-N; [M+H]+; 1-aminohex-5-yn-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.106; NWIIFKYGKOLKML-UHFFFAOYSA-N; [M+H]+; (1-aminocyclopent-3-en-1-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; XRLDSWLMHUQECH-UHFFFAOYSA-N; [M+H]+; cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; YBZQRYWKYBZZNT-BYPYZUCNSA-N; [M+H]+; (1R)-2,2-dimethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; UXKZFJDNFBNQHE-RITPCOANSA-N; [M+H]+; [(1S,4R)-4-aminocyclopent-2-en-1-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.022; UHSSZVLSEAEFTI-UHFFFAOYSA-N; [M+H]+; (3-amino-1-bicyclo[1.1.1]pentanyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; WYQKKRBHVXDDTB-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)bicyclo[1.1.1]pentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; VOABPFRENHXUQX-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; BKHTZJDZHRFTEW-UHFFFAOYSA-N; [M+H]+; 1,2,3,6-tetrahydropyridin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; YOQFMSBXAJNJJA-UHFFFAOYSA-N; [M+H]+; 1-amino-3-cyclopropylpropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; SFEYJTLKTWQWMB-HSUXUTPPSA-N; [M+H]+; [(1R,2S,5S)-3-azabicyclo[3.1.0]hexan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; BWKHTRYJANAUCO-UHFFFAOYSA-N; [M+H]+; 2-aminospiro[2.3]hexan-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.964; LMDVLNHRTIBTGT-UHFFFAOYSA-N; [M+H]+; 4-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; BHIQRZLQBMERJY-UHFFFAOYSA-N; [M+H]+; 5-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.958; SEHVUORORNIEOB-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.0]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.957; IXXBUEAWNGTYSS-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.957; TWQMJAQGXUVGOA-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; KMLPEYHLAKSCGX-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; AFLIGFFKSOPBNA-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; MNJYWTHQNUBTIC-RITPCOANSA-N; [M+H]+; (2S,3R)-2-ethenyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; SZEYBIHWBKIRJG-UHFFFAOYSA-N; [M+H]+; 4-oxaspiro[2.4]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; JPXSWTRRFQUJTC-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; BOTJOIYABJNMEW-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; NZCBOEIGQAQLCD-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[4.1.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; XFBQQBXIYXFYKY-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; YXNPVBNVXFDPHF-NTSWFWBYSA-N; [M+H]+; (1S,6S)-3-azabicyclo[4.1.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; VQIILGJJJQKLPC-PBXRRBTRSA-N; [M+H]+; (1R,5R,6S)-2-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; LSSWTAXATYJJOT-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; XSGGQEPWEZULLB-WDSKDSINSA-N; [M+H]+; (1R,5S)-3-azabicyclo[3.2.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; RJFSZMRLRWNKCP-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[3.1.1]heptan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; DVOBWGYOTJOCAJ-UHFFFAOYSA-N; [M+H]+; 3,4-dihydro-2H-pyran-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; HEOZZUBPQNUUPG-HSUXUTPPSA-N; [M+H]+; (1R,6R,7R)-2-oxabicyclo[4.1.0]heptan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; PNBUAUKWRXPJFK-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; ZFDMYXRXSBKBLF-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[3.1.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; WHCQIGAGLHHFPZ-JKUQZMGJSA-N; [M+H]+; (1S,4S,6R)-2-oxabicyclo[2.2.1]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; AHVAATWZOGWTOX-UHFFFAOYSA-N; [M+H]+; 1-methyl-2-oxabicyclo[2.1.1]hexan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; YJOCNEVFWOGVQR-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.2.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; QTSOGHFBXHIBFM-HCWXCVPCSA-N; [M+H]+; (1R,5S,6S)-2-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; NVHRHGWRVNFFIB-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; ILYYOUOYMCOHSN-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; GTYBCXLDMBKOHV-NTSWFWBYSA-N; [M+H]+; (1R,6S)-3-oxabicyclo[4.1.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; QQIZPINZVQELRS-UHFFFAOYSA-N; [M+H]+; 1-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; OOMIMZFFLZQKIU-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.933; HZAPWKALBWQUQD-UHFFFAOYSA-N; [M+H]+; 2-amino-1-cyclobutylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.928; JNABLKYNVDCEJC-UHFFFAOYSA-N; [M+H]+; 1-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; GMXKRJFFSCDIAQ-UHFFFAOYSA-N; [M+H]+; 1-[1-(aminomethyl)cyclopropyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; YGYOQZPGFXHQMW-XEAPYIEGSA-N; [M+H]+; [(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; JXSAWOLLGHOTJJ-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; OTCYOBLTAQTFPW-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.876; SSZMVNBVJGCVFK-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; OUFBLTGDJDQVTA-UHFFFAOYSA-N; [M+H]+; 2-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; AWZIRBSKQVRHQS-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.1.0]hexan-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; QOQPLUHKCHMZSQ-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; YFSGRMONVCFYTC-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-2,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.683; POOPWPIOIMBTOH-UHFFFAOYSA-N; [M+H]+; 8-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; BCNBMSZKALBQEF-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.655; XPMMAKUHNMSONL-UHFFFAOYSA-N; [M+H]+; 6-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.650; OTXCLTFNOJGVBN-UHFFFAOYSA-N; [M+H]+; 1-methoxypent-4-yn-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.631; REQJDKXJYIQOHX-UHFFFAOYSA-N; [M+H]+; 4-methoxypent-1-yn-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.615; PHGAOXNFCZKFTR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.614; NSRPFJGOCZUUHE-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.613; IYZVTTRRGCJXGK-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; HGVPKAGCVCGRDQ-UHFFFAOYSA-N; [M+H]+; 4,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; PTSGHGGLRADEFP-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.611; ZRBMHTFPJMSUDJ-UHFFFAOYSA-N; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.611; IAXUBUNOIDLOLR-UHFFFAOYSA-N; [M+H]+; 3,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.610; ZBCUGJNJBOSHIA-UHFFFAOYSA-N; [M+H]+; 4-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.596; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.583; XBZJFFHSLIVHCZ-NGJCXOISSA-N; [M+H]+; (1S,2R,4R)-7-azabicyclo[2.2.1]heptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.577; GHCVFTQJETWFTK-UHFFFAOYSA-N; [M+H]+; methyl 2-methylcyclopropane-1-carboximidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.574; DZOONCSMZVPSHJ-UHFFFAOYSA-N; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.569; GGTRPCOOMSVVMG-UHFFFAOYSA-N; [M+H]+; 4-methoxy-2-azabicyclo[2.1.1]hexane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.557; FILVIKOEJGORQS-UHFFFAOYSA-N; [M+H]+; 1,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.556; QWJRZIUNOYNJIQ-UHFFFAOYSA-N; [M+H]+; 2-ethyl-2-hydroxybutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.556; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.550; MNILDQSRDHCFJG-UHFFFAOYSA-N; [M+H]+; 3-oxa-8-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.547; GFDQQBBUZRWEIT-UHFFFAOYSA-N; [M+H]+; 3-methoxybicyclo[1.1.1]pentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.544; YNTUHDRALXNDEQ-UHFFFAOYSA-N; [M+H]+; 6-methoxy-2,3,4,5-tetrahydropyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.538; GMHPWGYTSXHHPI-UHFFFAOYSA-N; [M+H]+; azepan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.536; SIKTVUHUQZNEPY-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.535; KTWRIXHINMYODR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.533; HQQVXVKQOPZRBJ-UHFFFAOYSA-N; [M+H]+; 3,3a,4,5,6,6a-hexahydro-1H-furo[3,4-c]pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.533; FYCFJMPASVKULQ-UHFFFAOYSA-N; [M+H]+; 1-pyrrolidin-2-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.528; ZTXSXVWHVLDJQB-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.528; UUTGCNVYKLQLRV-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.527; QJIFFAMGOQBKPK-UHFFFAOYSA-N; [M+H]+; 6-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.527; SGNDFJVXTXKBGO-PHDIDXHHSA-N; [M+H]+; (1S,6R)-8-oxa-3-azabicyclo[4.2.0]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.527; QMXPTUUFGSTIKK-UHFFFAOYSA-N; [M+H]+; 5-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.525; ZHAIMJRKJKQNQI-UHFFFAOYSA-N; [M+H]+; 2-oxa-7-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.523; XKDPBYCPNJRCSM-UHFFFAOYSA-N; [M+H]+; 3,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -99.533; XRLDSWLMHUQECH; [M+H]+; Cyclopentancarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -116.132; XHLCYFVJQKWNRH; [M+H]+; Piperidine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -129.376; UXKZFJDNFBNQHE; [M+H]+; ((1s,4r)-4-aminocyclopent-2-enyl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.041; JBKVHLHDHHXQEQ; [M+H]+; Extrom 6m
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.495; VEZUQRBDRNJBJY; [M+H]+; Antioxidant D
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -142.085; DVOBWGYOTJOCAJ; [M+H]+; 2H-Pyran, 3,4-dihydro-2-aminomethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -142.890; UHSSZVLSEAEFTI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.090; VRVUKQWNRPNACD; [M+H]+; pentylisocyanate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.421; FYCFJMPASVKULQ; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.902; QPJCYJIZFCJYIR; [M+H]+; beta-Caprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.000; YGYOQZPGFXHQMW; [M+H]+; azabicyclohexanylmethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.438; UWJKJTAFQCZBLA; [M+H]+; Butanenitrile, 4-hydroxy-2,2-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.263; DZOONCSMZVPSHJ; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.007; RBCSSAWYWYRREH; [M+H]+; 3-propoxypropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.599; ZRBMHTFPJMSUDJ; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.332; XPMMAKUHNMSONL; [M+H]+; zlchem 1132
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.997; BMSYXLRQGIFLFO; [M+H]+; 3-Isopropoxypropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.631; KUQSQOIIMSDGFF; [M+H]+; Hexahydro-furo[2,3-c]pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.623; PHGAOXNFCZKFTR; [M+H]+; 3-Methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.920; YNTUHDRALXNDEQ; [M+H]+; o-Methylvalerolactim
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.174; QWJRZIUNOYNJIQ; [M+H]+; 3-Pentanone cyanohydrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.346; HOSRHDUJWMTWRD; [M+H]+; Pentane, 2-isocyanato-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.120; FEWLNYSYJNLUOO; [M+H]+; Formylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.928; TWQMJAQGXUVGOA; [M+H]+; 2-Azabicyclo[2.1.1]hexane-1-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.950; ZHAIMJRKJKQNQI; [M+H]+; 2-oxa-6-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.805; HUUPVABNAQUEJW; [M+H]+; zlchem 508
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.840; YBZQRYWKYBZZNT; [M+H]+; ACMC-20dplt
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.516; GXCJLVVUIVSLOQ; [M+H]+; 2-Propyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.916; SIKTVUHUQZNEPY; [M+H]+; 1-Methyl-3-piperidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.264; GGYVTHJIUNGKFZ; [M+H]+; N-methylpiperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.237; USXSCBCCYNVIPN; [M+H]+; (3-Bromo-phenyl)-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.470; LJJFNFYPZOHRHM; [M+H]+; Sestamibi
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.795; SAOOLIIHRNLCBT; [M+H]+; ACMC-20maot
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.921; QCKRFEBWZBKGTR; [M+H]+; 2-hydroxy-2,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.276; VCUVETGKTILCLC; [M+H]+; Lopac-D-5766
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.892; CEMLHCYKDRPMSS; [M+H]+; Methoxypivalonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.860; ZFPGARUNNKGOBB; [M+H]+; N-Ethylpyrrolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.144; UFWIDNCIQKQRIJ; [M+H]+; Butyrylethylenimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.687; WXYJAPNVTUNRQN; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.907; RHDNNKQDLVQQLJ; [M+H]+; 1-(propan-2-yl)aziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.126; FDCJCIRHYZNLDV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.148; IVKKELNYLUICGF; [M+H]+; 1-hydroxy-2,2-dimethyl-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.082; MJVIZWIQHKRBPI; [M+H]+; Aethoxen
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.124; GORGQKRVQGXVEB; [M+H]+; N-Ethyl-N-vinylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.219; QZSYZIDYWNAACS; [M+H]+; 4-ethyl-2,3-dihydro-1,4-oxazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.644; FILVIKOEJGORQS; [M+H]+; 1,5-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.819; ZCYVBYQBOWLNBU; [M+H]+; 1-(2-Methyl-1-oxopropyl)aziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.567; HGVPKAGCVCGRDQ; [M+H]+; 4,4-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.796; WDFKEEALECCKTJ; [M+H]+; N-propyl-2-propenamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.663; DVQLGAFYVKJEDE; [M+H]+; NN-Dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.716; FVEZUCIZWRDMSJ; [M+H]+; 2-Isopropyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.035; YFSGRMONVCFYTC; [M+H]+; ACMC-20aoff
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.090; AOCHNXXMYIQWEH; [M+H]+; Oxazole, 4,5-dihydro-2,4,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.496; BCNBMSZKALBQEF; [M+H]+; Pyrrolidinone, dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.396; HZRZMHNRCSIQFT; [M+H]+; 2,4,4-trimethyl-5H-oxazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.847; QPWSKIGAQZAJKS; [M+H]+; 4-(dimethylamino)-3-buten-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -296.513; FNMKFVXIVPDFBL; [M+H]+; 4-Methylaminopent-3-en-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.312; QNILTEGFHQSKFF; [M+H]+; Nipam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -300.260; XEXRMKMMZOZZIF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.781; JGAMOQYFDMQPRJ; [M+H]+; 3-(Dimethylamino)methacrylaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.457; QRWZCJXEAOZAAW; [M+H]+; N,N,2-Trimethylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -407.720; GZTXSSQZAMMARW; [M+H]+; 3,4,4-trimethyl-5H-1,3-oxazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.422; XRLDSWLMHUQECH; [M+H]+; Cyclopentancarboxamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H12N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.989
MS$FOCUSED_ION: PRECURSOR_M/Z 114.091347
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-3900000000-08277addeb4245da1775
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0180955 27.7682 55.018803 0.9451 9.33 0.3088 16 f{C3H3O1}/4.62ppm,p-C3H9N1
  55.0544572 24.9140 55.055165 0.7992 6.94 0.4647 16 f{C4H7}/4.19ppm,p-C2H5N1O1
  56.0497557 17.8673 56.050468 1.0348 8.23 0.5473 14 f{C3H6N1}/5.00ppm,p-C3H6O1
  67.0543760 27.3945 67.055117 0.9843 6.76 0.6176 16 f{C5H7}/2.23ppm,p-C1H5N1O1
  68.0496083 19.2551 68.050351 0.5731 4.77 0.2786 15 f{C4H6N1}/1.95ppm,p-C2H6O1
  69.0336282 27.9032 69.034371 0.8981 5.99 0.2765 16 f{C4H5O1}/1.98ppm,p-C2H7N1
  69.0700189 131.4382 69.070762 0.4778 20.31 0.8176 16 f{C5H9}/2.06ppm,p-C1H3N1O1
  70.0652507 33.6156 70.065994 1.0704 11.56 0.4500 15 f{C4H8N1}/1.78ppm,p-C2H4O1
  71.0492574 12.6512 71.050001 1.4778 4.91 0.3206 16 f{C4H7O1}/1.63ppm,p-C2H5N1
  71.0856156 11.0764 71.086359 1.3786 3.53 0.3647 16 f{C5H11}/1.25ppm,p-C1H1N1O1
  72.0444771 25.0167 72.045220 1.0549 6.77 -0.1794 16 f{C3H6N1O1}/1.21ppm,p-C3H6
  72.9372351 45.2575 72.937978 0.7404 8.24 0.5029 16 ?
  73.0469297 11.0625 73.047672 1.4237 2.75 0.7107 15 ?
  78.9498322 12.1408 78.950565 1.2793 4.49 0.3893 15 ?
  79.0543016 172.5992 79.055034 0.3921 23.50 0.6412 16 f{C6H7}/0.95ppm,p-H5N1O1
  86.0713177 147.1797 86.072024 0.4415 26.35 -0.0471 16 ?
  86.0963776 13.9085 86.097084 1.4635 3.19 0.3077 12 f{C5H12N1}/-0.56ppm,p-C1O1
  96.0808032 102.6651 96.081448 0.6661 15.87 0.5676 16 f{C6H10N1}/0.29ppm,p-H2O1
  97.0647803 40.9986 97.065417 1.1848 5.50 0.5147 16 f{C6H9O1}/-0.11ppm,p-H3N1
  98.0601409 17.1330 98.060770 1.1014 8.45 0.5110 13 f{C5H8N1O1}/1.03ppm,p-C1H4
  112.9998316 32.3115 113.000331 1.1150 17.35 0.5036 15 ?
  113.0233986 12.5283 113.023898 1.1414 4.37 0.4235 16 ?
  113.0597452 24.3578 113.060244 0.8226 6.15 0.6735 16 ?
  114.0662388 913.8333 114.066730 0.3857 135.79 0.0059 16 ?
  114.0913709 999.0000 114.091862 0.3594 141.20 1.0000 16 f{C6H12N1O1}/0.27ppm,p
  115.0629070 9.9312 115.063390 1.0516 1.73 0.1049 12 ?
  115.0696551 43.8091 115.070138 0.7648 8.89 -0.1643 15 ?
  115.0947110 70.9830 115.095194 0.8949 10.95 0.2794 16 ?
PK$NUM_PEAK: 28
PK$PEAK: m/z int. rel.int.
  55.018095 27.77 27
  55.054457 24.91 24
  56.049756 17.87 17
  67.054376 27.39 27
  68.049608 19.26 19
  69.033628 27.90 27
  69.070019 131.44 131
  70.065251 33.62 33
  71.049257 12.65 12
  71.085616 11.08 11
  72.044477 25.02 25
  72.937235 45.26 45
  73.046930 11.06 11
  78.949832 12.14 12
  79.054302 172.60 172
  86.071318 147.18 147
  86.096378 13.91 13
  96.080803 102.67 102
  97.064780 41.00 40
  98.060141 17.13 17
  112.999832 32.31 32
  113.023399 12.53 12
  113.059745 24.36 24
  114.066239 913.83 913
  114.091371 999.00 999
  115.062907 9.93 9
  115.069655 43.81 43
  115.094711 70.98 70
//
